Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ethicon Opens Up To Chronic Sinusitis Market With $785 Mil. Acclarent Buy

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson/Ethicon will use its $785 million acquisition of Acclarent, developer of the Balloon Sinuplasty system for chronic sinusitis, as a platform for growth in the ear, nose and throat business
Advertisement

Related Content

Blues’ TEC Delivers Mostly Negative Assessments For Three Technologies
Cook Medical Plans Rapid Scale-Up Of Newly Launched ENT Unit
J&J Q2 results
J&J Q2 results
J&J Spotlights AAA Device, Thermocool Extensions During Analyst Meeting
J&J Spotlights AAA Device, Thermocool Extensions During Analyst Meeting
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q4 2009
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q4 2009
Entellus Medical raises $30 million

Topics

Advertisement
UsernamePublicRestriction

Register

MT028300

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel